BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5446108)

  • 1. [Craniopharyngioma: renewed growth after the operation in spite of somatotropic hormone deficiency].
    Rosenberg D; David L; Bertrand J; Ruitton-Ugliengo A; Lapras C; Picot C; Monnet P
    Lyon Med; 1970 Apr; 223(16):847-57. PubMed ID: 5446108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Craniopharyngioma. Recovery of growth after surgery in spite of somatotropin deficiency].
    Rosenberg D; David L; Bertrand J; Ruitton-Ugliego A; Lapras C; Picot C; Monnet P
    Arch Fr Pediatr; 1970 Apr; 27(4):355-69. PubMed ID: 4316181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excessive growth and growth hormone deficiency after treatment for craniopharyngioma].
    López Siguero JP; García García E; Martínez-Aedo MJ; Martínez Valverde A
    An Esp Pediatr; 2000 Jul; 53(1):64-6. PubMed ID: 10998409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal growth with subnormal growth-hormone levels.
    Holmes LB; Frantz AG; Rabkin MT; Soeldner JS; Crawford JD
    N Engl J Med; 1968 Sep; 279(11):559-66. PubMed ID: 4299148
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth in children with a craniopharyngioma.
    Blethen SL
    Pediatrician; 1987; 14(4):242-5. PubMed ID: 2840646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Craniopharyngioma and eating disorders: report of two cases].
    de la Serna de Pedro I
    Actas Esp Psiquiatr; 2001; 29(2):139-41. PubMed ID: 11333533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest despite growth hormone replacement, post-craniopharyngioma surgery.
    DeVile CJ; Hayward RD; Neville BG; Grant DB; Stanhope R
    J R Soc Med; 1995 Apr; 88(4):227P-228P. PubMed ID: 7745571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amnestic syndrome in children. Observation of a girl after craniopharyngioma operation].
    Assal G; Campiche R; Thuillard F
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 127(2):189-97. PubMed ID: 7280581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior of somatotropic hormone (HCH) after stimulation with L-arginine and L-Dopa in a subject operated for craniopharyngioma].
    Esposito V; Bellastella A; D'Alessandro B; Iacono G; Montano A
    Boll Soc Ital Biol Sper; 1973 May; 49(10):592-8. PubMed ID: 4596400
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
    Niu DM; Guo WY; Pan HC; Wong TT
    Childs Nerv Syst; 2002 Apr; 18(3-4):164-5. PubMed ID: 11981627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth factor substitution after radical removal of craniopharyngioma].
    Feldkamp J; Scherbaum WA
    Dtsch Med Wochenschr; 1997 Oct; 122(42):1298-9. PubMed ID: 9378068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recombinant growth hormone for support of ovarian gonadotropin treatment in a hypophysectomized patient: a case-control study].
    De Geyter C; De Geyter M; Bals-Pratsch M; Castro E; Nieschlag E; Schneider HP
    Zentralbl Gynakol; 1995; 117(7):381-7. PubMed ID: 7668071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M; Smyczynska J; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniopharyngioma and Cushing disease: case report.
    Caceres A; Reitman AJ; Tomita T
    J Neurosurg; 2005 Apr; 102(3 Suppl):318-21. PubMed ID: 15881759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
    Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre- and postoperative endocrine function in children with craniopharyngioma ].
    Lucas C; Benderitter T; Choux M
    Arch Fr Pediatr; 1982 May; 39(5):303-7. PubMed ID: 7125828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum somatomedin activity in children after surgery for craniopharyngioma (authors transl)].
    Martinez MJ; Chaussain JL; Schimpff RM; Donnadieu M; Roger M; Job JC
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():881-6. PubMed ID: 7332440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine sequelae of surgically treated craniopharyngioma in children. Study of 7 recent cases].
    Pierron H; Charvet JP; Jacquet P; Raybaud C; Orsini A
    Pediatrie; 1971 Dec; 26(8):823-37. PubMed ID: 4333167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.